---
figid: PMC5362636__fbioe-05-00017-g002
figlink: /pmc/articles/PMC5362636/figure/F2/
number: Figure 2
caption: (A) Possible interplay between insulin-like growth factor (IGF)-1 and vascular
  endothelial growth factor (VEGF) receptor signaling pathways. They equally converge
  on ERK kinase, which fine-tune the activity of the main osteogenic transcription
  factor Runx2. IGF1 and VEGF also trigger PI3/AKT signaling pathway that can induce
  vasculogenesis or beta-catenin phosphorylation. On the contrary, non-phosphorylated
  beta-catenin acts as a pro-osteogenic factor regulating Runx2 and other genes. (B)
  consequences of IGF1 or IGF1/VEGF treatment on skin-derived multipotent stromal
  cells (S-MSCs) gene expression suggesting their commitment toward the endothelial
  phenotype. (C) Consequences of IGF1 or IGF1/VEGF treatment on PDPCs showing their
  main commitment toward the osteoblastic phenotype. Continuous lines indicate a marked
  effect, while dotted lines suggest a weaker regulation. Modified from Ferretti et
  al. ().
pmcid: PMC5362636
papertitle: 'Biofabrication and Bone Tissue Regeneration: Cell Source, Approaches,
  and Challenges.'
reftext: Monia Orciani, et al. Front Bioeng Biotechnol. 2017;5:17.
pmc_ranked_result_index: '128084'
pathway_score: 0.7839639
filename: fbioe-05-00017-g002.jpg
figtitle: Possible interplay between insulin-like growth factor (IGF)-1 and vascular
  endothelial growth factor (VEGF) receptor signaling pathways
year: '2017'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5362636__fbioe-05-00017-g002.html
  '@type': Dataset
  description: (A) Possible interplay between insulin-like growth factor (IGF)-1 and
    vascular endothelial growth factor (VEGF) receptor signaling pathways. They equally
    converge on ERK kinase, which fine-tune the activity of the main osteogenic transcription
    factor Runx2. IGF1 and VEGF also trigger PI3/AKT signaling pathway that can induce
    vasculogenesis or beta-catenin phosphorylation. On the contrary, non-phosphorylated
    beta-catenin acts as a pro-osteogenic factor regulating Runx2 and other genes.
    (B) consequences of IGF1 or IGF1/VEGF treatment on skin-derived multipotent stromal
    cells (S-MSCs) gene expression suggesting their commitment toward the endothelial
    phenotype. (C) Consequences of IGF1 or IGF1/VEGF treatment on PDPCs showing their
    main commitment toward the osteoblastic phenotype. Continuous lines indicate a
    marked effect, while dotted lines suggest a weaker regulation. Modified from Ferretti
    et al. ().
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FOXO4
  - AKT2
  - AKT1
  - IGF1
  - MAPK13
  - AKT3
  - FOXO3
  - MAPK10
  - RUNX2
  - FOXO6
  - FOXO1
  - MMP13
  - MAPK1
  - VEGFD
  - PGF
  - CTNNB1
  - MAPK14
  - MAPK3
  - MAPK12
  - MAPK9
  - VEGFC
  - CD34
  - BMP2
  - MAPK11
  - VEGFA
  - MAPK8
  - NIN
  - PECAM1
  - VEGFB
  - Cancer
genes:
- word: Foxo
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO4
  entrez: '4303'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: IGF1
  symbol: IGF1
  source: hgnc_symbol
  hgnc_symbol: IGF1
  entrez: '3479'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Foxo
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO3
  entrez: '2309'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: Runx2
  symbol: RUNX2
  source: hgnc_symbol
  hgnc_symbol: RUNX2
  entrez: '860'
- word: Foxo
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO6
  entrez: '100132074'
- word: Foxo
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: MMP13
  symbol: MMP13
  source: hgnc_symbol
  hgnc_symbol: MMP13
  entrez: '4322'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: Bcatenin
  symbol: BCATENIN
  source: bioentities_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: CD31,CD34
  symbol: CD34
  source: hgnc_symbol
  hgnc_symbol: CD34
  entrez: '947'
- word: Bmp-2
  symbol: BMP2
  source: hgnc_symbol
  hgnc_symbol: BMP2
  entrez: '650'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: В-сатеnin
  symbol: NIN
  source: hgnc_symbol
  hgnc_symbol: NIN
  entrez: '51199'
- word: CD31,CD34
  symbol: CD31
  source: hgnc_alias_symbol
  hgnc_symbol: PECAM1
  entrez: '5175'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
